MedTrace Logo

Ondansetron and the QT Interval In Adult Emergency Department Patients

NCT01759420 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2014-06-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the use of the medication ondansetron (zofran) in the emergency department. There are studies of the ability of ondansetron to cause a prolongation in the QT interval (a certain measurement on an EKG) in anesthesia and cancer patients, but not on emergency department patients. This is an observational study where patients that are going to receive the anti-nausea medicine ondansetron in the emergency department will have an EKG performed every 2 minutes for 20 minutes to determine if the QT interval prolongs and returns to normal in that time period. Any serious outcomes will be reported. There is expected to be no adverse outcomes from this routinely used medication.

Conditions

  • Ondansetron

Interventions

DRUG

Ondansetron

4mg of intravenous ondansetron

Sponsors & Collaborators

  • Madigan Army Medical Center

    collaborator FED

  • C.R.Darnall Army Medical Center

    lead FED

Principal Investigators

  • Peter M Moffett, MD · Carl R Darnall Army Medical Center Department of Emergency Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01759420 on ClinicalTrials.gov